Study Summary
This trial is testing whether the drug apixaban is better than warfarin for people with a certain kind of heart condition.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 9 Secondary · Reporting Duration: 24 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Warfarin
1 of 2
Apixaban
1 of 2
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: Apixaban · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 99 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there other instances in which Apixaban has been used for research purposes?
"At the moment, there are a total of 69 clinical trials in progress that involve Apixaban. 23 of these live studies are classified as Phase 3 research. The majority of the Apixaban clinical trials are based in Montreal, but there are 1,446 locations worldwide where these medical studies are taking place." - Anonymous Online Contributor
Has Apixaban been cleared by the FDA?
"While there is some data indicating Apixaban's safety, it only received a score of 2 because this is a Phase 2 trial and thus there is no clinical evidence yet affirming its efficacy." - Anonymous Online Contributor
Are there specific inclusion or exclusion criteria for this research study?
"This particular clinical trial has room for 40 participants that have heart failure and are between 18-99 years old. Additionally, these applicants must also have had a HeartMate 3 LVAD implanted." - Anonymous Online Contributor
What benefits does this experiment hope to bring patients?
"The success of this clinical trial, which will be assessed over the course of 24 weeks, is measured by a patient's freedom from death or any negative events related to hemocompatibility (such as stroke, device thrombosis, bleeding, aortic root thrombus, and arterial non-CNS thromboembolism). Additionally, secondary outcomes include Survival free of aortic root thrombus and hemorrhagic stroke. Lastly, all-cause mortality will be compared between each study arm." - Anonymous Online Contributor
How many guinea pigs are a part of this test?
"That is correct. According to the clinicaltrials.gov website, this trial is currently looking for 40 patients at 1 location. The original posting was on December 14th, 2021 and there have been no updates since February 21st, 2022." - Anonymous Online Contributor
Does this research still have positions available for participants?
"This clinical trial, which was first posted on December 14th 2021, is still recruiting participants according to the latest update on February 21st 2022." - Anonymous Online Contributor
Are adults outside of the age limit of 20 years old able to participate in this research?
"The age requirements to participate in this clinical trial are between 18-99 years old." - Anonymous Online Contributor
What is the most common reason that doctors prescribe Apixaban?
"Apixaban is frequently used to dissolve deep vein thrombosis, but it can also be employed to ameliorate cerebrovascular accident, systemic embolism, and myocardial infarction." - Anonymous Online Contributor